CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy

Clinical trial NCT00635492 · COMPLETED

Trial details

NCT number: NCT00635492
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus

Start date: 2008-01-01
Primary completion: 2011-12-01
Enrollment: 2515

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.